Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 8/20 | 0.79 |
| ▸ | NPC1 | O15118 | 7/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.69 |
| ▸ | POLB | P06746 | 3/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 4/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | RECQL | P46063 | 1/20 | 0.63 |
| ▸ | CASP6 | P55212 | 1/20 | 0.63 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.63 |
| ▸ | KDR | P35968 | 1/20 | 0.63 |
| ▸ | HTT | P42858 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30117873 | 1.00 | RAB9A (0.79) | RAB9ANPC1KMT2APOLBSMN1; SMN2 | |
| SCHEMBL1520680 | 0.89 | RAB9A (0.77) | RAB9ANPC1KMT2APOLBSMN1; SMN2 | |
| SCHEMBL9867050 | 0.89 | RAB9A (1.00) | RAB9ANPC1KMT2APOLBSMN1; SMN2 | |
| SCHEMBL14082273 | 0.88 | RAB9A (0.72) | RAB9ANPC1KMT2APOLBSMN1; SMN2 | |
| SCHEMBL14542182 | 0.86 | RAB9A (0.78) | RAB9ANPC1KMT2APOLBSMN1; SMN2 | |
| SCHEMBL27578898 | 0.85 | KDR (0.65) | RAB9ANPC1KMT2APOLBSMN1; SMN2 | |
| SCHEMBL11837615 | 0.84 | RAB9A (0.76) | RAB9ANPC1KMT2APOLBSMN1; SMN2 | |
| SCHEMBL11837609 | 0.84 | RAB9A (0.76) | RAB9ANPC1KMT2APOLBSMN1; SMN2 | |
| SCHEMBL979284 | 0.83 | RAB9A (0.74) | RAB9ANPC1KMT2APOLBSMN1; SMN2 | |
| SCHEMBL9868569 | 0.83 | RAB9A (0.74) | RAB9ANPC1KMT2APOLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112430216-B | Preparation method of benzimidazole compound in pesticide | 六夫丁作物保护有限公司 | 2022-12-09 | — | — | CN | disclosed |
| CN-112430216-A | Preparation method of benzimidazole compound in pesticide and pesticide | 苏州帆木云智能科技有限公司 | 2021-03-02 | — | — | CN | disclosed |
| US-7799918-B2 | Organic metal complexes | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2010-09-21 | — | — | US | disclosed |
| US-7799918-B2 | Organic metal complexes | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2010-09-21 | — | — | US | disclosed |
| US-7799918-B2 | Organic metal complexes | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2010-09-21 | — | — | US | disclosed |
| US-20080214818-A1 | Organic metal complexes | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE | 2008-09-04 | — | — | US | disclosed |
| US-20080214818-A1 | Organic metal complexes | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE | 2008-09-04 | — | — | US | disclosed |
| US-20080214818-A1 | Organic metal complexes | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE | 2008-09-04 | — | — | US | disclosed |
| US-5077408-A | PROCESS FOR THE SYNTHESIS OF OXAZOLOPYRIDINE COMPOUNDS | SCIENCE ET ORGANISATION (FR) | 1991-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214818-A1 | Organic metal complexes | C5, C9, C1S | RAB9A 382/4885NPC1 1517/4885KMT2A 1902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.